ArticleCell communication and signaling : CCS2020

Targeting the orphan nuclear receptor NR2F6 in T cells primes tumors for immune checkpoint therapy.

Victoria Klepsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.